Showcasing the most successful biopharmaceutical companies in France.

BioFrance is a growing and successful biotech community. France has established itself as a contender among Europe’s leading biopharmaceutical hotbeds, ranking fifth in Phase III public company pipelines in Europe, according to Ernst & Young. With a rise in venture capital, BioFrance shows promise of continuing expansion and development of products and research.

Join the World Discussion Forum


Hotbed News
First-Ever CRISPR Trial Points to Looming Problems Wednesday, June 29, 2016
If Spurned By Medivation (MDVN), Sanofi (SNY) May Turn to BioMarin (BMRN) for a Little Love Monday, June 20, 2016
Sanofi (SNY) Inks Deal to Swap Business with Boehringer Ingelheim Wednesday, June 29, 2016
3 Tips that Could Help Biotech Investors Make Big Bucks Wednesday, June 08, 2016
Paris Prosecutors to Determine Whether Criminal Mistakes Were Made in Bial-Biotrial's Fatal Drug Trial Thursday, June 23, 2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer Thursday, June 16, 2016
New Four-Strain Influenza Vaccine, VaxigripTetra, Regulatory Dossier From Sanofi Pasteur (SASY.PA) Now Approved In Europe Thursday, June 23, 2016
Sanofi (SNY) Could Use the Same Tactics on Medivation (MDVN) that Were Instrumental in Acquiring Genzyme in 2011 Friday, June 24, 2016
Antibiotics Upstart Allecra Nabs $24.7 Million Series B Financing Wednesday, June 15, 2016
ABIVAX Release: Analysis Of Ongoing ABX203 Phase IIb/III Trial In Chronic Hepatitis B Virus Infection Shows Good Safety, But Primary Endpoint Of Study Is Unlikely To Be Reached Monday, June 20, 2016
12345678910